Clinical and Radiological Outcomes of Medacta Shoulder System (BE)

NCT05002335 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-09-29

No results posted yet for this study

Summary

This is a post-market surveillance study on Medacta Shoulder System

Conditions

  • Primary Osteoarthritis
  • Secondary Osteoarthritis
  • Rotator Cuff Tear Arthropathy
  • Rheumatoid Arthritis Shoulder
  • Avascular Necrosis
  • Fracture
  • Revision of Shoulder Arthroplasty

Interventions

DEVICE

Medacta Shoulder System

Performance of Total Shoulder Arthroplasty (anatomic/reverse) with Medacta Shoulder System

Sponsors & Collaborators

  • Medacta International SA

    lead INDUSTRY

Principal Investigators

  • Bart Berghs, MD · AZ Sint-Jan (Brugge, Belgium)

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-06
Primary Completion
2026-02-28
Completion
2027-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05002335 on ClinicalTrials.gov